loader image

Dutch Committee Seeks to Expedite MDMA-Assisted Therapy for PTSD

Reading Time: < 1 minute



Coverage by Oliver Longstaff for Pα+, edited by Josh Hardman. Last month, we learned that the Psychopharmacologic Drugs Advisory Committee (PDAC), convened by the FDA to advise on the potential approval of MDMA-assisted therapy to treat patients with PTSD, had delivered a negative verdict: 10-1 against the notion that the therapeutic benefits outweigh the risks involved.
Source



Source link

share this article
  • This field is for validation purposes and should be left unchanged.

Subscribe to receive the latest business and industry news in your inbox.

  • This field is for validation purposes and should be left unchanged.

latest from the industry
PSYCHEDELICS news

Whitepaper

  • This field is for validation purposes and should be left unchanged.

  • This field is for validation purposes and should be left unchanged.

Use